AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Conference - Boston, MA, United States
Hosted by the American Association for Cancer Research, the National Cancer Institute, and the European Organisation for Research and Treatment of Cancer, the 2013 Molecular Targets and Cancer Therapeutics conference will bring together an estimated 3,000 academics, scientists, and pharmaceutical industry representatives from across the globe to discuss innovations in drug development, target selection, and the impact of new discoveries in molecular biology.
During the last few years, numerous innovative agents have been discovered as a result of tremendous developments in the understanding of the molecular basis of cancer. Further clinical progress in cancer treatment will be accomplished mainly through the conduct of translational research projects, efficient new drug development and the execution of large, prospective, randomized, multicentre cancer clinical trials. This requires a joint and global approach, and early and optimal exchange of information.
(Courtesy of International Conference on Molecular Targets and Cancer Therapeutics' logo, via abstractsonline.com)
AACR Molecular Targets and Cancer Therapeutics
October 19-23, 2013
Hynes Convention Center, Boston, MA, USA
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
